Consistent with the in vitro findings, elevation of the core-associated marker CD44 was observed in mouse GBM tumors by co-injection of edge-like GBM spheres with core-like spheres at a ratio of 95:5, but not edge-like alone (Fig. 3g and Supplementary Fig. 4f). This evidence concerns the gene CD44 and glioblastoma.